Kroger, Albertsons and others allege an unlawful monopoly in one legal case and aim to recover overcharges for a drug in ...

Biotech venture capital is risky business, inherently at the mercy of regulators and binary outcomes. Now it may face a new ...

The Trump administration said in mid-April to expect tariffs on drug imports in a month or so, which puts the deadline ...

The executive order adds on to Trump’s planned tariffs on pharmaceuticals in his overall strategy to onshore production of ...

Trump wanted to advance the ‘most favored nation’ policy in his first term but faced resistance from industry and the courts.

A new executive order aims to smooth the path for getting U.S. manufacturing facilities up and running; HHS says it will ...

Merck broke ground on a $1B, 470K SF biotech facility last month at the Chestnut Run Innovation & Science Park in Wilmington, ...

On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...

President Donald Trump signed an executive order Monday directing the Food and Drug Administration to accelerate approvals ...

When limited to only Big Pharma companies, the highest rated were Roche ... At the heart of the reputation decline are drug pricing issues. Only 14% of patient groups said that the industry had a good ...

Exclusive-US FDA Asks Some Fired Pharma User Fee Negotiation Staff to Return By Patrick Wingrove (Reuters) -The U.S. Food and Drug Administration is asking some of its recently fired staff ...